Serum Institute of India joins global network to boost production of affordable outbreak vaccines
1 year, 1 month ago

Serum Institute of India joins global network to boost production of affordable outbreak vaccines

The Hindu  

The Serum Institute of India will join a growing CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future disease outbreaks. The addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions, and take it a step closer to achieving the 100 Days Mission. The manufacturing network will focus on vaccine makers in the Global South near areas at high risk of outbreaks caused by deadly viral threats like Lassa Fever, Nipah, Disease X, and other pathogens with epidemic or pandemic potential prioritised by CEPI. The release quoted Richard Hatchett, CEO of CEPI:“As part of CEPI’s global manufacturing network, SII’s world-renowned manufacturing and rapid response capabilities are poised to play a critical role in enabling swift and equitable access to affordable outbreak vaccines for the Global South.” Adar Poonawalla, CEO of SII, commented: “As a leading vaccine manufacturer, we’re committed to utilising our well-established manufacturing and rapid response capabilities to strengthen epidemic preparedness and increase access to life-saving vaccines for those who need them most at an affordable price.

Global Manufacturing Global South Outbreak Vaccines South Vaccine Rapid 100 Days Cepi Sii  outbreak  manufacturing  rapid  institute  india  south  pandemic  production  vaccine  serum  boost  vaccines  cepi  joins  epidemic  outbreaks  network  global

History of this topic

We envisage health as central to development, development as key to global cooperation: EAM
3 weeks, 2 days ago

We envisage health as central to development, development as key to global cooperation: EAM

Hindustan Times  

New Delhi, India envisages health as central to development, and development as key to international cooperation, External Affairs Minister S Jaishankar said on Saturday as he cited the 'Vaccine Maitri' initiative of the Centre during the Covid period, and the medical aid extended to people in Ukraine, Afghanistan and other countries in recent years. We envisage health as central to …

Serum Institute to manufacture Mpox vaccine by Danish maker Bavarian Nordic
Trending News
3 months ago

Serum Institute to manufacture Mpox vaccine by Danish maker Bavarian Nordic

Hindustan Times  

Pune-based Serum Institute of India will be manufacturing Danish vaccine company Bavarian Nordic’s vaccine against mpox— MVA-BN— locally for the Indian market, according to latter’s statement issued on Monday on the license and manufacturing agreement signed between the two companies. “… Under the agreement, the companies will undertake a technology transfer of the current manufacturing process for MVA-BN® to SII …

Global Pandemic Threat: 100 Days to Save Lives
4 months, 3 weeks ago

Global Pandemic Threat: 100 Days to Save Lives

Hindustan Times  

A modelling study suggests that if a vaccine for SARS-CoV-2 had been developed within 100 days, an estimated 8.3 million deaths could have been averted globally. The study also estimated that productivity losses due to illness amounting to almost $1.4 trillion and $63 billion of hospitalisation costs would have been averted globally.

Serum Institute 'hopeful' of producing Mpox vaccine, says CEO Adar Poonawalla
6 months, 3 weeks ago

Serum Institute 'hopeful' of producing Mpox vaccine, says CEO Adar Poonawalla

India TV News  

The Serum Institute of India announced on Tuesday that it is actively developing a vaccine for Monkeypox, with positive results anticipated within a year. Serum Institute's vaccine development efforts Serum Institute of India is working on a Monkeypox vaccine to address the global health emergency declared by the WHO. The vaccine is expected to be ready within a year, according …

Vaccinating India: Triumphs and Challenges on the Road to Full Coverage
8 months, 3 weeks ago

Vaccinating India: Triumphs and Challenges on the Road to Full Coverage

News 18  

Vaccines have come a long way since Dr Edward Jenner first inoculated an eight-year-old boy against smallpox in 1796. Since 1974, the EPI has boosted global newborn immunisation coverage against DTP from 5 per cent to 84 per cent in India. This program aims to reach every child and pregnant woman who missed routine immunisation due to the Covid pandemic, …

With State prod, India can be world leader in vaccines
1 year, 1 month ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 4 months ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

Bolster the US-India vaccine collaboration
1 year, 8 months ago

Bolster the US-India vaccine collaboration

Hindustan Times  

As India and the United States look to step up their strategic technology partnership, the former is in an advantageous position in the shifting collaborative paradigm — a confident democracy with a robust and resilient research and development ecosystem. Well supported by globally competitive academic research organisations such as the Indian Council for Medical Research - National Institute of Virology, …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 9 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 11 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

Covid vaccine mission is a lesson for the world
2 years ago

Covid vaccine mission is a lesson for the world

Hindustan Times  

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. India’s response to the pandemic highlighted the underlying strengths of our scientific and technological prowess Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and …

‘India’s contribution to Covid vaccines has been tremendous’: CEPI chief
2 years ago

‘India’s contribution to Covid vaccines has been tremendous’: CEPI chief

Hindustan Times  

Richard Hatchett, CEO of CEPI who is on a visit to India, spoke to HT about the country gaining attention globally by manufacturing and developing anti-Covid vaccines in less than a year, and lessons learnt from the pandemic. Did the fact that India developed and produced Covid vaccines in less than a year catch global attention? And it wasn’t just …

Serum Institute to establish CoE for infectious diseases in Telangana
2 years ago

Serum Institute to establish CoE for infectious diseases in Telangana

Deccan Chronicle  

Hyderabad: Vaccine maker Serum Institute of India on Sunday announced that it would set up a 'Centre of Excellence' for Infectious Diseases and Pandemic Preparedness here. The centre “Dr Cyrus Poonawalla Center of Excellence for Infectious Diseases and Pandemic Preparedness” will be located at the Indian Institute of Public Health, a release said. Rama Rao said: "The opening of this …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years, 2 months ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

How prepared is India for future epidemics? Experts discuss at THSTI meet
2 years, 3 months ago

How prepared is India for future epidemics? Experts discuss at THSTI meet

Hindustan Times  

The first day of the international meet on preparedness for future epidemics saw academicians, industrialists and policy makers deliberating on synergistic collaborations between academia and industry to help achieve faster vaccine development. Experts discuss at THSTI meet The Translational Health Science and Technology Institute, an autonomous research institute of Department of Biotechnology under the central government's Ministry of Science and …

The Largest Vaccination Drive: Victory of People, Process and Technology
2 years, 5 months ago

The Largest Vaccination Drive: Victory of People, Process and Technology

News 18  

On the occasion of the celebration of 75 years of India’s Independence, Azadi Ka Amrit Mahotsav, the Government of India under the leadership of PM Narendra Modi was able to inoculate over a billion people with more than 217 crore vaccination doses across different age groups, diverse communities and regions within the span of 18 months after the general availability …

The outline of an essential global pandemic treaty
2 years, 6 months ago

The outline of an essential global pandemic treaty

The Hindu  

COVID-19 would count as being among some of the most severe pandemics the world has seen in the last 100 years. India produces nearly 60% of the world’s vaccines and is said to account for 60%-80% of the United Nations’ annual vaccine procurement — “vaccine diplomacy” or “vaccine maitri” with a commitment against health inequity. As of 2021, India shipped …

How India Pursued Covid-19 Vaccine Diplomacy Amid Vaccine Nationalism By Rich Nations
2 years, 7 months ago

How India Pursued Covid-19 Vaccine Diplomacy Amid Vaccine Nationalism By Rich Nations

ABP News  

The last 30 months have seen the world getting ravaged by Covid-19. When rich nations of the Global North were stockpiling and hoarding Covid-19 vaccines, many times more than their population, India not only spearheaded one of the largest vaccine drives within the country but also shared the vaccine doses with low- and middle-income countries worldwide. India supplied 23.9 crore …

Serum institute prepares to import Monkeypox vaccine in India amid global worry
2 years, 7 months ago

Serum institute prepares to import Monkeypox vaccine in India amid global worry

Live Mint  

With India having reported four Monkeypox cases so far, the Serum Institute of India has said that it is negotiating the import of a small of the vaccine with the Danish firm Bavarian Nordic, reported PTI. Quoting SII CEO Adar Poonawalla, the news agency stated in case of a collaboration, it may take two to three months to get the …

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine
2 years, 8 months ago

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine

India Today  

The Centre has invested in developing a strain specific vaccine that would help in countering the changing nature of coronavirus. An official who facilitated developing this ecosystem for second generation vaccines told India Today that research and development work is underway to develop strain-specific vaccines in India. A bivalent vaccine will target the specific spike mutations seen in the Omicron …

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence
2 years, 8 months ago

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence

News 18  

With the UK-India week on the cusp, it becomes pertinent to discuss how the United Kingdom and India have weathered rough storms during the pandemic years to come out closer than ever. It is this three-way partnership that has now been at the helm of having already delivered over 2 billion affordable, effective vaccines which have now been administered to …

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora
2 years, 9 months ago

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora

News 18  

Not so long back, a reputed international media-house had predicted gloomily that it could take over a decade for India to vaccinate its 1.4 billion population against Covid-19. The resounding success of this drive, which has been a proactive, pre-emptive, and graded response in the management of Covid-19 has been a myth-breaker on several fronts in the public health space …

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing
2 years, 9 months ago

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing

The Hindu  

Hailing India for ramping up its COVID-19 vaccine manufacturing at the right time and for ensuring supplies to the rest of the world, leaders at the World Economic Forum on Monday said everyone else needs to follow the Indian model to ensure vaccine equity and wider inoculation. Bucher said India has been a good example and the same needs to …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 11 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

BRICS grouping should work together to support vaccine endeavours: Health Minister
2 years, 11 months ago

BRICS grouping should work together to support vaccine endeavours: Health Minister

The Hindu  

India, having one of the world’s largest vaccine manufacturing industries that supplied vaccines to more than 150 countries and met 65-70% of the World Health Organisation’s vaccine requirements, is willing to offer its robust vaccine manufacturing industry for developing vaccines for BRICS, as well as the world,” Union Health Minister Dr. Mansukh Mandaviya said on Tuesday while launching the BRICS …

UK pledges £160m to help accelerate vaccine development
3 years ago

UK pledges £160m to help accelerate vaccine development

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Foreign Secretary Liz Truss said: …

Covid-19 | India Likely To Supply Covovax, Corbevax Vaccines To Quad Partners: Report
3 years, 1 month ago

Covid-19 | India Likely To Supply Covovax, Corbevax Vaccines To Quad Partners: Report

ABP News  

New Delhi: India on Friday conveyed to the Quad partners that New Delhi is open to supplying Covid-19 vaccines, including Covovax and Corbevax, manufactured in the country under the vaccine partnership. “As pandemic continues to impact us, we have undertaken collective efforts to address global health security, Quad vaccine initiative and our collective vaccine delivery. Australian Foreign Minister Marise Payne …

India's Covid-19 vaccination drive, one year on | Recap
3 years, 2 months ago

India's Covid-19 vaccination drive, one year on | Recap

India Today  

One year ago, India set out on the challenging journey of vaccinating its massive 1.38 billion-strong population against Covid-19. In the year since the country’s vaccination drive began, 90 per cent of the eligible population has received the first dose and 60 per cent has got their second dose too. More than 156 crore vaccine doses have been administered in …

Give full authorisation to Covishield: Serum Institute of India
3 years, 2 months ago

Give full authorisation to Covishield: Serum Institute of India

Hindustan Times  

NEW DELHI: Pune-based Serum Institute of India on Friday announced it has applied to India’s drugs regulator for full market authorisation to Covishield, its anti-Covid vaccine, citing adequate availability of the required data. The government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF and @MoHFW_INDIA for this permission,” Adar Poonawalla, …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
3 years, 2 months ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines
3 years, 2 months ago

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines

The Hindu  

Heralding a new frontier in India’s vaccination programme, the apex drug regulator has approved two more vaccines under emergency use authorisation, and an antiviral drug. Despite three vaccines being available, India has overwhelmingly been reliant on Covishield and that is a matter of concern as a new chapter in the vaccination programme unfolds. The new directives say that “precaution doses”, …

India-US healthcare collaboration in spotlight as India approves 2 more Covid vaccines
3 years, 2 months ago

India-US healthcare collaboration in spotlight as India approves 2 more Covid vaccines

India Today  

India-US collaboration in the health sector is in the spotlight as the Central Drug Authority this week approved two more Covid vaccines - Corbevax and Covovax - and antiviral drug Molnupiravir for use in India. Indian companies working with Texas Children's, Baylor College of Medicine's National School of Tropical Medicine; Dr. Peter Hotez, Prof and Dean of the National School …

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII
3 years, 2 months ago

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII

News 18  

Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world. He was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Control Organisation, has approved the SII's vaccine Covovax for …

As Omicron cases grow, why hasn’t India started a Covid vaccine booster programme?
3 years, 2 months ago

As Omicron cases grow, why hasn’t India started a Covid vaccine booster programme?

The Independent  

While the Omicron variant has sparked a worldwide rush for more vaccines, with the standard two doses feared to be insufficient, India, where Delta wreaked havoc just a few months ago, is yet to decide whether a third dose is needed. “I think the virus is more widespread than is reported.” The current tally of Covid cases in India is …

Serum Institute-Novavax's anti-COVID vaccine gets emergency use listing from WHO
3 years, 2 months ago

Serum Institute-Novavax's anti-COVID vaccine gets emergency use listing from WHO

Firstpost  

Adar Poonawalla, the CEO of Serum Institute of India, hailed WHO’s decision as “yet another milestone” in the fight against COVID-19. New Delhi: The World Health Organisation on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global health body against the …

WHO approves Serum Institute's Covovax for emergency approval
3 years, 3 months ago

WHO approves Serum Institute's Covovax for emergency approval

Op India  

The World Health Organisation on Friday approved the emergency use for Serum Institute of India’s Covovax, vaccine developed by the Serum Institute of India in partnership with the US-based Novavax, for showing excellent safety and efficacy. With this approval, Covovax became the 9th Covid-19 vaccine to be permitted for emergency use, providing a boost to ongoing efforts to vaccinate more …

India needs vaccines that can quickly adapt to corona variants: VK Paul
3 years, 3 months ago

India needs vaccines that can quickly adapt to corona variants: VK Paul

India Today  

Amid the Omicron threat, Niti Aayog member Dr VK Paul said on Tuesday that there is a potential scenario that our Covid-19 vaccines may become ineffective and India should have vaccine platforms that are 'adaptable quickly' with changing nature of the coronavirus variants. Addressing an event organised by industry body CII, the Covid Task Force chief called for modifying the …

Omicron’s lesson: We’re not covid-safe until everyone is
3 years, 3 months ago

Omicron’s lesson: We’re not covid-safe until everyone is

Live Mint  

Omicron, the newly designated variant of concern has a few mutations reported earlier in the Beta and Lambda variants of Sars-CoV-2, both of which displayed some immune escape. Omicron has emerged from Africa, a continent that has just 7% of its total population fully vaccinated, while more than tenfold this proportion of people have received both shots in many rich …

India offers vaccines, other help including essential life-saving drugs to Omicron-affected nations
3 years, 3 months ago

India offers vaccines, other help including essential life-saving drugs to Omicron-affected nations

India TV News  

Highlights Supplies can be undertaken through Covax or bilaterally, the MEA said The Government of India stands ready to support the countries affected in Africa, MEA said The new Covid variant -- Omicron -- was first reported in South Africa The Central government on Monday offered 'Made in India' vaccine supply and other help to the countries dealing with the …

India’s Serum Institute resumes vaccine exports to COVAX
3 years, 3 months ago

India’s Serum Institute resumes vaccine exports to COVAX

Associated Press  

NEW DELHI — The Serum Institute of India, the world’s largest vaccine maker, resumed exports of coronavirus vaccines to the U.N.-backed COVAX distribution program on Friday after halting most overseas sales in March. At the time, Serum Institute had contracts to provide COVAX with 200 million doses of AstraZeneca vaccines, and unfinalized agreements to supply 350 million more. New infections …

SII resumes Covishield exports under COVAX
3 years, 3 months ago

SII resumes Covishield exports under COVAX

The Hindu  

The Serum Institute of India on Friday officially announced that it has resumed exports of its COVID-19 vaccine Covishield under the international vaccine sharing programme COVAX. The resumption of exports is linked to the SII surpassing its original target to produce one billion doses of Covishield by this year’s end, a statement issued by SII said, adding that it had …

India’s Serum Institute resumes vaccine exports to COVAX
3 years, 3 months ago

India’s Serum Institute resumes vaccine exports to COVAX

Al Jazeera  

The world’s largest vaccine maker halted shipments of COVID shots in March as India saw an explosion in infections. The Serum Institute of India, the world’s largest vaccine maker, has resumed exports of coronavirus vaccines to the UN-backed COVAX distribution programme after halting most overseas sales in March. At the time, Serum Institute had contracts to provide COVAX with 200 …

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success
3 years, 4 months ago

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success

Firstpost  

Representatives from seven vaccine makers — Serum Institute of India, Bharat Biotech, Dr Reddy’s Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech — participated in the meeting Prime Minister Narendra Modi on Saturday met Indian COVID-19 vaccine manufacturers who said his leadership was a key factor in India being able to administer 100 crore doses of the jabs …

India Ships Vaccines to Nepal, Bangladesh, Myanmar and Iran under 'Vaccine Maitri'
3 years, 5 months ago

India Ships Vaccines to Nepal, Bangladesh, Myanmar and Iran under 'Vaccine Maitri'

News 18  

India has recently sent crores of Covid vaccine shots to four nations in its neighborhood under the “Vaccine Maitri” programme, it was announced on Thursday. Ministry of External Affairs spokesperson Arindam Bagchi said that India has exported the Covid vaccines to Nepal, Bangladesh, Myanmar, and Iran and its “top priority” is the neighborhood countries. India resumed vaccines export in the …

Come, make vaccines in India: PM Modi to global manufacturers in UNGA address
3 years, 5 months ago

Come, make vaccines in India: PM Modi to global manufacturers in UNGA address

Firstpost  

Making a strong pitch for indigenious COVID-19 vaccines, Modi also informed at UNGA that India has developed the first DNA vaccine, which can be given to those above 12 years Making a strong pitch for indigenious COVID-19 vaccines, Prime Minister Narendra Modi during his address at UNGA invited the global manufacturers to make them in India. “Despite limited resources, India …

PM Modi at UNGA invites global manufacturers to come and make vaccines in India
3 years, 5 months ago

PM Modi at UNGA invites global manufacturers to come and make vaccines in India

India TV News  

PM Modi at UNGA invites global manufacturers to come and make vaccines in India Modi also announced that India has developed the first DNA vaccine, which can be given to people older than 12 years. Mourning the loss of lives lost due to the global coronavirus pandemic, Prime Minister Narendra Modi during his address at the 76th session of the …

Quad leaders welcome India's decision to resume export of Covid-19 vaccines
3 years, 5 months ago

Quad leaders welcome India's decision to resume export of Covid-19 vaccines

India Today  

The Quad countries — the United States, India, Japan, and Australia — welcomed India’s announcement to resume exports of safe and effective Covid-19 vaccines, including to Covax, from October. Read | Modi-Biden meet: Talks focus on trade, Covid; leaders vow to strengthen Indo-US ties "The Quad leaders welcome Biological E LTD’s production, including through our Quad investments, of at least …

Vaccine Certification Must Meet Minimum Criteria, Working With India on 'Phased Approach': UK
3 years, 5 months ago

Vaccine Certification Must Meet Minimum Criteria, Working With India on 'Phased Approach': UK

News 18  

A day after UK added Serum Institute’s Covishield to its expanded travel advisory, the government has said Covid-19 vaccine certification from all countries must meet a minimum criteria and it is working with India on a phased approach to its international travel norms. With India’s vaccine certification not on a list of 18 approved countries, Indian travellers to the UK …

International travel should be made easier via mutual recognition of vaccine certificates: PM at COVID Summit
3 years, 5 months ago

International travel should be made easier via mutual recognition of vaccine certificates: PM at COVID Summit

India TV News  

Emphasising the need to address the economic effects of the COVID-19 pandemic, Prime Minister Narendra Modi on Wednesday said that international travel should be made easier through mutual recognition of vaccine certificates. Addressing the Global COVID-19 Summit, the Prime Minister also said the supply chains of raw materials must be kept open for the production of vaccines against the disease. …

Discover Related